The World of GLP-1 Agonists: A Game-Changer in Diabetes and Obesity Treatment
GLP-1 receptor agonists have revolutionized diabetes and obesity management, offering new hope for patients worldwide. These drugs mimic the incretin…
Tag: Drugs
10 best weight-loss drugs
1. Zepbound (Tirzepatide) 2. Wegovy (Semaglutide) 3. Mounjaro (Tirzepatide) 4. Saxenda (Liraglutide) 5. Qsymia (Phentermine/Topiramate) 6. Contrave (Naltrexone/Bupropion) 7. Rybelsus…
Eli Lilly’s Mounjaro (Tirzepatide) Targets Emerging Markets: A Game-Changer for Global Obesity?
Eli Lilly and Company, a global pharmaceutical leader, announced plans to launch its blockbuster weight-loss drug Mounjaro (tirzepatide) in emerging markets by…
Liraglutide in 2025: Diabetes, Weight Loss, and New Updates
Key Highlights What is Liraglutide? Liraglutide is a GLP-1 receptor agonist, a class of medications revolutionizing type 2 diabetes treatment…
Weight Loss Market Outlook 2030: Growth Drivers & Key Segments
The $1.5 Trillion Weight Loss Economy of 2030: A Breakdown of the Market Reshaping Health By 2030, the global weight…
Next Up in Obesity Drugs: A Timeline of What’s Coming to Market (2026–2028+)
The fight against obesity is entering an exciting new era. With blockbuster drugs like Wegovy (semaglutide) and Zepbound (tirzepatide) already…
Orforglipron: The Oral Alternative to Injection-Based Weight Loss and Diabetes Drugs
Key Highlights: A New Hope for Obesity and Diabetes Obesity and type 2 diabetes (T2D) are global health crises, affecting 1…